MISC

2005年

Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung Cancer Study Group.

Cancer J

11: 417-24

エクスポート
BibTeX RIS